BEGIN:VCALENDAR VERSION:2.0 METHOD:PUBLISH PRODID:-//Telerik Inc.//Sitefinity CMS 13.3//EN BEGIN:VTIMEZONE TZID:UTC BEGIN:STANDARD DTSTART;VALUE=DATE:20230101 TZNAME:UTC TZOFFSETFROM:+0000 TZOFFSETTO:+0000 END:STANDARD END:VTIMEZONE BEGIN:VEVENT DESCRIPTION:Chair: Alun Bedding\, Director\, GlaxoSmithKline Speaker: Timo thy H Montague\, GlaxoSmithKline \nSequential design approaches for bioequ ivalence studies with crossover designs \nCo-authors: Diane Potvin\, Charl es E. DiLiberti\, Walter W. Hauck\, Alan F. Parr\, Donald J. Schuirmann an d Robert A. Smith \nPharmaceutical Statistics\, Volume 7\, Issue 4\, Octob er/December 2008\, Pages: 245&ndash\;262 \nPlus information from: \nAddit ional results for &lsquo\;Sequential design approaches for bioequivalence studies with crossover designs&rsquo\; \n(Subsequently published in: Phar maceutical Statistics\, Volume 11\, Issue 1\, pages 8&ndash\;13\, January/ February 2012) Abstract | Paper+ | \;Slides Speaker: Ileana Baldi\, U nit of Cancer Epidemiology\, CeRMS and CPO Piemonte\, University of Turin \nPlanning a Bayesian early-phase phase I/II study for human vaccines in H ER2 carcinomas \nCo-authors: Sarah Zohar\, Guido Forni\, Franco Merletti\, Giuseppe Masucci and Dario Gregori \nPharmaceutical Statistics\, Volume 1 0\, Issue 3\, pages 218&ndash\;226\, May/June 2011 Abstract | Paper+ | Sli des + Papers available to view from 14th July 2011 \;to 11th August 20 11. For a flier advertising the event\, please click here.  \; DTEND:20110721T153000Z DTSTAMP:20240328T161347Z DTSTART:20110721T140000Z LOCATION: SEQUENCE:0 SUMMARY:Journal Club - Early Phase Clinical Trials UID:RFCALITEM638472392277737418 X-ALT-DESC;FMTTYPE=text/html:
Chair: Alun Bedding\, Dire ctor\, GlaxoSmithKline
Speaker: Timothy H Montagu
e\, GlaxoSmithKline
\nSequential design approaches for bioequivalenc
e studies with crossover designs
\nCo-authors: Diane Potvin\, Charle
s E. DiLiberti\, Walter W. Hauck\, Alan F. Parr\, Donald J. Schuirmann and
Robert A. Smith
\nPharmaceutical Statistics\, Volume 7\, Issue 4\,
October/December 2008\, Pages: 245&ndash\;262
\nPlus informat
ion from:
\nAdditional results for &lsquo\;Sequential design approac
hes for bioequivalence studies with crossover designs&rsquo\;
\n(Subsequently published in: Pharmaceutical Statistics\, Volume 11\, Iss
ue 1\, pages 8&ndash\;13\, January/February 2012)
Abstract | Paper+
| \;Slides
Spe
aker: Ileana Baldi\, Unit of Cancer Epidemiology\, CeRMS and CPO
Piemonte\, University of Turin
\nPlanning a Bayesian early-phase pha
se I/II study for human vaccines in HER2 carcinomas
\nCo-authors: Sa
rah Zohar\, Guido Forni\, Franco Merletti\, Giuseppe Masucci and Dario Gre
gori
\nPharmaceutical Statistics\, Volume 10\, Issue 3\, pages 218&n
dash\;226\, May/June 2011
Abstract | Paper+ | Slides